Oral Cavity Squamous Cell Carcinoma and Readmission: Rates, Causes, and Risk Factors.

We sought to comprehend the rates and causes of unplanned hospital readmission within 60 days following oral cancer surgery

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Oral Cavity Squamous Cell Carcinoma; Readmission Carcinoma Carcinoma, Squamous Cell Head and Neck Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Squamous Cell Carcinoma of Head and Neck

Sex eligibility

All sexes

Study type

Observational

Primary location

King Abdulaziz University Hospital

Jeddah, 21589, Saudi Arabia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all patient underwent oral cancer surgery in king Abdulaziz University hospital

Exclusion criteria

significant missing data

Treatment and study plan

No intervention

Other

no intervention

Primary outcomes

rate of readmission

Time frame: 60 days after discharge

the number of readmitted patients within 60 days following oral cancer surgery

Sponsors and collaborators

Lead sponsor

Abdulsalam Alqutub

Other

Registry information

Important dates

Study start: 2023
Primary completion: 2023
Study completion: 2024
First posted: Feb 14, 2024
Registry last updated: Feb 14, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed